Technical Analysis for MDP - Medexus Pharmaceuticals Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Up | Up | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Narrow Range Bar | Range Contraction | 0.00% | |
Upper Bollinger Band Walk | Strength | 0.00% | |
Inside Day | Range Contraction | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Overbought Stochastic | Strength | 0.00% | |
Upper Bollinger Band Walk | Strength | -0.71% | |
Wide Bands | Range Expansion | -0.71% | |
Above Upper BB | Strength | -0.71% | |
Overbought Stochastic | Strength | -0.71% | |
Up 3 Days in a Row | Strength | -0.71% |
Get a Trading Sidekick!
- Earnings date: 2024-09-20
Medexus Pharmaceuticals Inc. Description
Medexus Pharmaceuticals Inc, formerly Pediapharm Inc, is a Canada-based company engaged in pharmaceutical business sector. The Company is a North American focused, specialty pharmaceutical business that operates through three segments: Medac Pharma USA, a fully integrated commercial infrastructure focused on auto-immune diseases in the United States; Medexus Pharma Canada, a fully integrated commercial infrastructure focused on auto-immune disease and pediatric diseases in Canada; and a Business Development function, which works to maintain its product pipeline. The Company's flag products are Rasuvo and Metoject, a formulation of methotrexate (auto-pen and pre-filled syringe) designed to treat rheumatoid arthritis and other auto-immune diseases; and Rupall, an allergy medication. The Company provides products for the healthcare professionals and patients.
Classification
Keywords: Health Healthcare Infrastructure Pipe Pharma Pipeline Pharmaceutical Integrated Disease Drugs Pharmaceuticals Diseases Arthritis Medication Immunosuppressants Rheumatoid Arthritis Cnx Nifty Pharmaceutical Business Sector Pharmaceutical Industry In China
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 3.16 |
52 Week Low | 1.44 |
Average Volume | 31,829 |
200-Day Moving Average | 2.047 |
50-Day Moving Average | 2.457 |
20-Day Moving Average | 2.322 |
10-Day Moving Average | 2.532 |
Average True Range | 0.148 |
RSI (14) | 67.11 |
ADX | 33.25 |
+DI | 35.137 |
-DI | 17.151 |
Chandelier Exit (Long, 3 ATRs) | 2.476 |
Chandelier Exit (Short, 3 ATRs) | 2.154 |
Upper Bollinger Bands | 2.874 |
Lower Bollinger Band | 1.770 |
Percent B (%b) | 0.93 |
BandWidth | 47.571 |
MACD Line | 0.097 |
MACD Signal Line | 0.015 |
MACD Histogram | 0.0825 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 2.905 | ||||
Resistance 3 (R3) | 2.917 | 2.893 | 2.888 | ||
Resistance 2 (R2) | 2.893 | 2.867 | 2.888 | 2.882 | |
Resistance 1 (R1) | 2.847 | 2.850 | 2.835 | 2.835 | 2.876 |
Pivot Point | 2.823 | 2.823 | 2.818 | 2.818 | 2.823 |
Support 1 (S1) | 2.777 | 2.797 | 2.765 | 2.765 | 2.724 |
Support 2 (S2) | 2.753 | 2.780 | 2.748 | 2.718 | |
Support 3 (S3) | 2.707 | 2.753 | 2.713 | ||
Support 4 (S4) | 2.695 |